Salivary gland tumours affect the parotid gland in 80% of cases, the submandibular gland in 10-15% of cases, while the sublingual gland is rarely affected (in 5-10% of cases) [1, 2]. 80% of parotid gland tumours and 50% of submandibular gland tumours are benign. This is a retrospective descriptive study within the Department of Otorhinolaryngology of the Specialty Hospital of the CHU Ibn Sina of Rabat, involving 84 patients hospitalized for management of a tumor of the main salivary glands (parotid and submandibular) over a 4-year period from September 2015 to September 2019.The median age of our patients was 42 years with extremes of 7 and 80 years. The average age of patients with a benign tumour was 40 years. The average age of patients with a malignant tumour was 54 years. The sex ratio was 0.58. We didn’t find any specific risk factors in our patients. The average time between onset of symptoms and consultation was 38 months with extremes ranging from 2 to 120 months (10 years). In malignant tumours of the salivary glands, there is no predominance of sex, and the average age of discovery is between 55 and 65 years. For Dale [4], the majority of parotid cancers occur between the ages of 50 and 60, 2% of these tumours occur in children and 16% in subjects under the age of 30. Through our literature review, we found no risk factors specific to parotid tumours. Some authors report a risk of salivary gland tumours from exposure to silica dust [5]. Salivary gland tumours are common, but most often they are benign. 80% of parotid gland tumours and 50% of submandibular gland tumours are benign. Parotid involvement is dominated by pleomorphic adenoma, and submandibular involvement is dominated by chronic lithiasic maxillite.